SCHEMBL9196231

SCHEMBL9196231

CC(C)Cc1nc2ccc(C(c3cccc(Cl)c3)n3ccnc3)cc2[nH]c1=O

nearest known ligand 0.57

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 11/20 0.57
CYP26A1 O43174 2/20 0.57
CYP3A4 P08684 1/20 0.57
CYP2C8 P10632 1/20 0.57
CYP2D6 P10635 1/20 0.57
CYP2C9 P11712 1/20 0.57
CYP24A1 Q07973 1/20 0.57
CYP26B1 Q9NR63 1/20 0.57
FNTA P49354 1/20 0.44
FNTB P49356 1/20 0.44
CNR1 P21554 3/20 0.42
TBXAS1 P24557 1/20 0.38
PDE3B Q13370 1/20 0.38
PDE3A Q14432 1/20 0.38
CYP17A1 P05093 1/20 0.37
EGFR P00533 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9194639 0.93 CYP19A1 (0.56) CYP19A1CYP26A1CYP3A4CYP2C8CYP2D6
Water SCHEMBL9727730 0.85 CYP19A1 (0.61) CYP19A1CYP26A1CYP3A4CYP2C8CYP2D6
SCHEMBL10102763 0.83 CYP19A1 (0.57) CYP19A1CYP26A1CYP3A4CYP2C8CYP2D6
SCHEMBL9192629 0.82 CYP17A1 (0.43) CYP26A1CYP3A4CYP17A1
SCHEMBL12336821 0.81 CYP19A1 (0.52) CYP19A1CYP26A1CYP3A4CYP2C8CYP2D6
SCHEMBL12336931 0.80 CYP11B1 (0.46) CYP19A1CYP26A1CYP3A4CYP2C8CYP2D6
SCHEMBL9198108 0.78 CYP19A1 (0.60) CYP19A1CYP26A1CYP3A4CYP2C8CYP2D6
SCHEMBL10102687 0.77 CYP19A1 (0.64) CYP19A1CYP26A1CYP3A4CYP2C8CYP2D6
SCHEMBL1626417 0.77 CYP19A1 (0.55) CYP19A1CYP26A1CYP3A4CYP2C8CYP2D6
SCHEMBL12337076 0.76 CYP19A1 (0.53) CYP19A1CYP26A1CYP3A4CYP2C8CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0371564-B1 (1H-azol-1-ylmethyl)substituted quinoline, quinazoline or quinoxaline derivatives JANSSEN PHARMACEUTICA NV (BE) 1995-07-12 EP disclosed
US-5151421-A Compounds for inhibition of metabolism of retinoids, for treatment for proliferation of epithelial cells and keratin disorders JANSSEN PHARMACEUTICA N.V. (BE) 1992-09-29 US disclosed
US-5028606-A Retinoid metabolism inhibitors JANSSEN PHARMACEUTICA N.V. (BE) 1991-07-02 US disclosed